Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study

被引:2
作者
Yang, Qing [1 ]
Huang, Deyu [2 ]
Jiang, Longlin [1 ]
Tang, Yuan [1 ]
Zeng, Dingfen [1 ]
机构
[1] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Clin Res Ctr Canc, Sichuan Canc Ctr,Affiliated Canc Hosp,Nursing Dept, Chengdu, Peoples R China
[2] Chengdu Med Coll, Sch Nursing, Chengdu, Peoples R China
关键词
SF-6D; FACT-H&N; thyroid carcinoma; mapping study; health utility; OUTCOME MEASURES; FUNCTIONAL ASSESSMENT; QUALITY; CANCER; EQ-5D; MODELS;
D O I
10.3389/fendo.2023.1160882
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: There is limited evidence for mapping clinical tools to preference-based generic tools in the Chinese thyroid cancer patient population. The current study aims to map the FACT-H&N (Functional Assessment of Cancer Therapy-Head and Neck Cancer) to the SF-6D (Short Form Six-Dimension), which will inform future cost-utility analyses related to thyroid cancer treatment. Methods: A total of 1050 participants who completed the FACT-H&N and SF-6D questionnaires were included in the analysis. Four methods of direct and indirect mapping were estimated: OLS regression, Tobit regression, ordered probit regression, and beta mixture regression. We evaluated the predictive performance in terms of root mean square error (RMSE), mean absolute error (MAE), concordance correlation coefficient (CCC), Akaike information criterion (AIC) and Bayesian information criterion (BIC) and the correlation between the observed and predicted SF-6D scores. Results: The mean value of SF-6D was 0.690 (SD = 0.128). The RMSE values for the fivefold cross-validation as well as the 30% random sample validation for multiple models in this study were 0.0833-0.0909, MAE values were 0.0676-0.0782, and CCC values were 0.6940-0.7161. SF-6D utility scores were best predicted by a regression model consisting of the total score of each dimension of the FACT-H&N, the square of the total score of each dimension, and covariates including age and gender. We proposed to use direct mapping (OLS regression) and indirect mapping (ordered probit regression) to establish a mapping model of FACT-H&N to SF-6D. The mean SF-6D and cumulative distribution functions simulated from the recommended mapping algorithm generally matched the observed ones. Conclusions: In the absence of preference-based quality of life tools, obtaining the health status utility of thyroid cancer patients from directly mapped OLS regression and indirectly mapped ordered probit regression is an effective alternative.
引用
收藏
页数:13
相关论文
共 49 条
[1]   Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia [J].
Abdin, Edimansyah ;
Chong, Siow Ann ;
Seow, Esmond ;
Verma, Swapna ;
Tan, Kelvin Bryan ;
Subramaniam, Mythily .
QUALITY OF LIFE RESEARCH, 2019, 28 (01) :177-186
[2]   Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis [J].
Adams, Roisin ;
Walsh, Cathal ;
Veale, Douglas ;
Bresnihan, Barry ;
FitzGerald, Oliver ;
Barry, Michael .
PHARMACOECONOMICS, 2010, 28 (06) :477-487
[3]   A Comparison of Direct and Indirect Methods for the Estimation of Health Utilities from Clinical Outcomes [J].
Alava, Monica Hernandez ;
Wailoo, Allan ;
Wolfe, Fred ;
Michaud, Kaleb .
MEDICAL DECISION MAKING, 2014, 34 (07) :919-930
[4]   Exploring the consistency of the SF-6Dv2 in a breast cancer population [J].
Ameri, Hosein ;
Safari, Hossein ;
Poder, Thomas .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (05) :1017-1024
[5]   Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients [J].
Ameri, Hosein ;
Yousefi, Mahmood ;
Yaseri, Mehdi ;
Nahvijou, Azin ;
Arab, Mohammad ;
Sari, Ali Akbari .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (01) :89-96
[6]   Mapping WOMAC Onto the EQ-5D-5L Utility Index in Patients With Hip or Knee Osteoarthritis [J].
Bilbao, Amaia ;
Martin-Fernandez, Jesus ;
Garcia-Perez, Lidia ;
Carlos Arenaza, Juan ;
Ariza-Cardiel, Gloria ;
Ramallo-Farina, Yolanda ;
Ansola, Laura .
VALUE IN HEALTH, 2020, 23 (03) :379-387
[7]   Deriving a preference-based single index from the UK SF-36 Health Survey [J].
Brazier, J ;
Usherwood, T ;
Harper, R ;
Thomas, K .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1115-1128
[8]   A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures [J].
Brazier, John E. ;
Yang, Yaling ;
Tsuchiya, Aki ;
Rowen, Donna Louise .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2010, 11 (02) :215-225
[9]  
Chang Joseph Tung-chieh, 2008, Chang Gung Med J, V31, P384
[10]   Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx) [J].
Cheng, Hui Lin ;
Molassiotis, Alex .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (01) :56-62